Aldeyra Therapeutics Inc (NASDAQ: ALDX) on Friday, soared 7.89% from the previous trading day, before settling in for the closing price of $5.32. Within the past 52 weeks, ALDX’s price has moved between $1.14 and $7.20.
Healthcare Sector giant saw their annual sales surged by 15.99% over the last five years. The company achieved an average annual earnings per share of 17.66%. With a float of $57.94 million, this company’s outstanding shares have now reached $60.05 million.
Aldeyra Therapeutics Inc (ALDX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Aldeyra Therapeutics Inc is 3.27%, while institutional ownership is 57.76%. The most recent insider transaction that took place on Aug 13 ’25, was worth 13,250. In this transaction Principal Financial Officer of this company bought 2,500 shares at a rate of $5.30, taking the stock ownership to the 2,500 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Development Officer sold 22,073 for $5.15, making the entire transaction worth $113,713. This insider now owns 221,799 shares in total.
Aldeyra Therapeutics Inc (ALDX) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.25 earnings per share (EPS) for the period topping the consensus outlook (set at -0.26) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.66% per share during the next fiscal year.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators
Aldeyra Therapeutics Inc (ALDX) is currently performing well based on its current performance indicators. A quick ratio of 2.82 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.85, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach 0.15 in one year’s time.
Technical Analysis of Aldeyra Therapeutics Inc (ALDX)
Analysing the last 5-days average volume posted by the [Aldeyra Therapeutics Inc, ALDX], we can find that recorded value of 0.55 million was lower than the volume posted last year of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 83.45%.
During the past 100 days, Aldeyra Therapeutics Inc’s (ALDX) raw stochastic average was set at 89.62%, which indicates a significant decrease from 98.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was lower than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.36, while its 200-day Moving Average is $4.60. Now, the first resistance to watch is $5.90. This is followed by the second major resistance level at $6.06. The third major resistance level sits at $6.37. If the price goes on to break the first support level at $5.43, it is likely to go to the next support level at $5.12. Should the price break the second support level, the third support level stands at $4.96.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Key Stats
Market capitalization of the company is 343.80 million based on 59,896K outstanding shares. Right now, sales total 0 K and income totals -55,850 K. The company made 0 K in profit during its latest quarter, and -9,770 K in sales during its previous quarter.
